570 research outputs found
The role of rendering in relation to the BSE epidemic, the development of EU animal byâproduct legislation and the reintroduction of rendered products into animal feeds
The bovine spongiform encephalopathy (BSE) epidemic in 1986 highlighted the importance of the rendering industry as a key component of the food supply chain. Prior to 1986 the rendering industry was poorly understood. However, following the emergence of BSE research was commissioned to characterise rendering systems and investigate their ability to inactivate transmissible spongiform encephalopathy (TSE) agents. Six rendering systems were found to be operational in Europe but their key process parameters, such as particle size, process temperature and transit time, were poorly characterised. This review describes how these key process parameters were determined and used to inform protocols for the subsequent TSE inactivation trials which subsequently shaped both EU legislation and the development of techniques used to validate rendering systems. It also describes how EU legislation banning the use of animalâderived proteins in animal feeds ('feed ban') effectively eliminated the market for meat and bone meal (MBM) and how the rendering industry sought to 'add value' to rendered products by conducting research to support the development of new markets for rendered products. The nutritional, environmental and economic characteristics of modern processed animal proteins (PAPs) mean that they represent valuable ingredients for use in animal feeds. Recent research has paved the way for legislative changes allowing the safe reintroduction of nonruminant PAP into aquaâfeeds and may soon facilitate their reintroduction into pig and poultry feeds. However, resistance from key stakeholders in the food chain remains a significant challenge that must be overcome before their full potential can be realised. Further research is required to characterise modern PAPS and to ensure their appropriate, safe and acceptable inclusion in animal feeds
A long-acting GH receptor antagonist through fusion to GH binding protein.
Acromegaly is a human disease of growth hormone (GH) excess with considerable morbidity and increased mortality. Somatostatin analogues are first line medical treatment but the disease remains uncontrolled in up to 40% of patients. GH receptor (GHR) antagonist therapy is more effective but requires frequent high-dose injections. We have developed an alternative technology for generating a long acting potent GHR antagonist through translational fusion of a mutated GH linked to GH binding protein and tested three candidate molecules. All molecules had the amino acid change (G120R), creating a competitive GHR antagonist and we tested the hypothesis that an amino acid change in the GH binding domain (W104A) would increase biological activity. All were antagonists in bioassays. In rats all antagonists had terminal half-lives >20 hours. After subcutaneous administration in rabbits one variant displayed a terminal half-life of 40.5 hours. A single subcutaneous injection of the same variant in rabbits resulted in a 14% fall in IGF-I over 7 days. IN CONCLUSION: we provide proof of concept that a fusion of GHR antagonist to its binding protein generates a long acting GHR antagonist and we confirmed that introducing the W104A amino acid change in the GH binding domain enhances antagonist activity
Comparison of local pole assignment methods
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76770/1/AIAA-20171-818.pd
Pregnancy Reprograms the Epigenome of Mammary Epithelial Cells and Blocks the Development of Premalignant Lesions
Pregnancy causes a series of cellular and molecular changes in mammary epithelial cells (MECs) of female adults. In addition, pregnancy can also modify the predisposition of rodent and human MECs to initiate oncogenesis. Here, we investigate how pregnancy reprograms enhancer chromatin in the mammary epithelium of mice and influences the transcriptional output of the oncogenic transcription factor cMYC. We find that pregnancy induces an expansion of the active cis-regulatory landscape of MECs, which influences the activation of pregnancy-related programs during re-exposure to pregnancy hormones in vivo and in vitro. Using inducible cMYC overexpression, we demonstrate that post-pregnancy MECs are resistant to the downstream molecular programs induced by cMYC, a response that blunts carcinoma initiation, but does not perturb the normal pregnancy-induced epigenomic landscape. cMYC overexpression drives post-pregnancy MECs into a senescence-like state, and perturbations of this state increase malignant phenotypic changes. Taken together, our findings provide further insight into the cell-autonomous signals in post-pregnancy MECs that underpin the regulation of gene expression, cellular activation, and resistance to malignant development
Critical point network for drainage between rough surfaces
In this paper, we present a network method for computing two-phase flows between two rough surfaces with significant contact areas. Low-capillary number drainage is investigated here since one-phase flows have been previously investigated in other contributions. An invasion percolation algorithm is presented for modeling slow displacement of a wetting fluid by a non wetting one between two rough surfaces. Short-correlated Gaussian process is used to model random rough surfaces.The algorithm is based on a network description of the fracture aperture field. The network is constructed from the identification of critical points (saddles and maxima) of the aperture field. The invasion potential is determined from examining drainage process in a flat mini-channel. A direct comparison between numerical prediction and experimental visualizations on an identical geometry has been performed for one realization of an artificial fracture with a moderate fractional contact area of about 0.3. A good agreement is found between predictions and observations
A novel D2O tracer method to quantify RNA turnover as a biomarker of de novo ribosomal biogenesis, in vitro, in animal models, and in human skeletal muscle
Current methods to quantify in vivo RNA dynamics are limited. Here, we developed a novel stable isotope (D2O) methodology to quantify RNA synthesis (i.e., ribosomal biogenesis) in cells, animal models, and humans. First, proliferating C2C12 cells were incubated in D2O-enriched media and myotubes ±50 ng/ml IGF-I. Second, rat quadriceps (untrained, n = 9; 7-wk interval-âlikeâ training, n = 13) were collected after ~3-wk D2O (70 atom %) administration, with body-water enrichment monitored via blood sampling. Finally, 10 (23 ± 1 yr) men consumed 150-ml D2O followed by 50 ml/wk and undertook 6-wk resistance exercise (6 Ă 8 repetitions, 75% 1-repetition maximum 3/wk) with body-water enrichment monitored by saliva sampling and muscle biopsies (for determination of RNA synthesis) at 0, 3, and 6 wk. Ribose mole percent excess (r-MPE) from purine nucleotides was analyzed via GC-MS/MS. Proliferating C2C12 cell r-MPE exhibited a rise to plateau, whereas IGF-I increased myotube RNA from 76 ± 3 to 123 ± 3 ng/ÎŒl and r-MPE by 0.39 ± 0.1% (both P < 0.01). After 3 wk, rat quadriceps r-MPE had increased to 0.25 ± 0.01% (P < 0.01) and was greater with running exercise (0.36 ± 0.02%; P < 0.01). Human muscle r-MPE increased to 0.06 ± 0.01 and 0.13 ± 0.02% at 3/6 wk, respectively, equating to synthesis rates of ~0.8%/day, increasing with resistance exercise to 1.7 ± 0.3%/day (P < 0.01) and 1.2 ± 0.1%/day (P < 0.05) at 3/6 wk, respectively. Therefore, we have developed and physiologically validated a novel technique to explore ribosomal biogenesis in a multimodal fashion
Microscopic theories of neutrino-^{12}C reactions
In view of the recent experiments on neutrino oscillations performed by the
LSND and KARMEN collaborations as well as of future experiments, we present new
theoretical results of the flux averaged and
cross sections. The approaches used are
charge-exchange RPA, charge-exchange RPA among quasi-particles (QRPA) and the
Shell Model. With a large-scale shell model calculation the exclusive cross
sections are in nice agreement with the experimental values for both reactions.
The inclusive cross section for coming from the decay-in-flight of
is to be compared to the experimental value
of , while the one due to
coming from the decay-at-rest of is which
agrees within experimental error bars with the measured values. The shell model
prediction for the decay-in-flight neutrino cross section is reduced compared
to the RPA one. This is mainly due to the different kind of correlations taken
into account in the calculation of the spin modes and partially due to the
shell-model configuration basis which is not large enough, as we show using
arguments based on sum-rules.Comment: 17 pages, latex, 5 figure
Recommended from our members
Genetically engineered multicistronic allele of Pmel yielding highly specific CreERT2-mediated recombination in the melanocyte lineage
YesGenetic approaches that allow lineage tracing are essential to our future understanding of melanocytes and melanoma. To date, the approaches used to label melanocytes in mice have relied on random integration of transgenes driven by the promoters of the Tyrosinase and Dopachrome tautomerase genes, knock-in to the Dopachrome tautomerase locus or knock-in to the Mlana locus in a bacterial artificial chromosome. These strategies result in expression in other tissues such as telencephalon and other cell types such as nerves. Here we used homologous recombination in mouse embryonic stem cells to generate a targeted multicistronic allele of the Pmel locus that drives melanocyte-specific expression of CreERT2, nuclear localised H2B-Cerulean and membrane localised marcks-mKate2 allowing live imaging of melanocytes and activation of other conditional alleles. We combined this allele with R26R-EYFP mice allowing induction of EYFP expression on administration of tamoxifen or its metabolite 4-OHT. The fluorescent proteins H2B-Cerulean and marcks-mKate2 label the cell nucleus and plasma membrane respectively allowing live imaging and FACS isolation of melanoblasts and melanocytes as well as serving to provide an internal control allowing estimation of recombination efficiency after administration of tamoxifen. We demonstrate the utility of the transgene in embryonic and adult tissues.Cancer Research UK. Grant Number: A15673. Medical Research Council. Grant Number: MC_PC_U127527200. National Centre for the Replacement Refinement and Reduction of Animals in Research. Grant Number: NC/K001612/1. North West Cancer Research Fund. Grant Number: CR1132. Medical Research Scotland. Grant Number: 436FR
Avalanche Dynamics in Evolution, Growth, and Depinning Models
The dynamics of complex systems in nature often occurs in terms of
punctuations, or avalanches, rather than following a smooth, gradual path. A
comprehensive theory of avalanche dynamics in models of growth, interface
depinning, and evolution is presented. Specifically, we include the Bak-Sneppen
evolution model, the Sneppen interface depinning model, the Zaitsev flux creep
model, invasion percolation, and several other depinning models into a unified
treatment encompassing a large class of far from equilibrium processes. The
formation of fractal structures, the appearance of noise, diffusion with
anomalous Hurst exponents, Levy flights, and punctuated equilibria can all be
related to the same underlying avalanche dynamics. This dynamics can be
represented as a fractal in spatial plus one temporal dimension. We develop
a scaling theory that relates many of the critical exponents in this broad
category of extremal models, representing different universality classes, to
two basic exponents characterizing the fractal attractor. The exact equations
and the derived set of scaling relations are consistent with numerical
simulations of the above mentioned models.Comment: 27 pages in revtex, no figures included. Figures or hard copy of the
manuscript supplied on reques
Turnover of passerine birds on islands in the Aegean Sea (Greece)
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73442/1/j.1365-2699.2007.01695.x.pd
- âŠ